Skip to main content
. 2021 May 26;18(5):e1003632. doi: 10.1371/journal.pmed.1003632

Table 2. Baseline characteristics of n = 22 splenectomy patients in Papua, Indonesia.

Parameters All splenectomy patients n = 22 Subgroups *P. vivax vs P. falciparum subgroup comparison p-value
Asymptomatic P. vivax n = 7 Asymptomatic P. falciparum n = 13 Asymptomatic mixed P. vivax-P. falciparum n = 1 Uninfected control n = 1
Age in years (median [IQR]) 24.5 (18.3–36.8) 25 (19–36) 20 (15.5–39.5) 28 32 0.47
Sex (n/N of males, [%]) 15/22 (68.2) 4/7 (57.1) 9/13 (69.2) 1 (100) 1 (100) 0.65
Ethnicity (n/N of Papuans, [%]) 15/22 (68.2) 4/7 (57.1) 10/13 (76.9) 1 (100) 0 0.61
Splenectomy due to trauma (n/N, %) 20/22 (90.9) 6/7 (85.7) 12/13 (92.3) 1 (100) 1 (100) 0.65
Splenectomy due to splenomegaly (n/N, %) 2/22 (9.1) 1/7 (14.3) 1/13 (7.7) 0 0 1
Body temp. in °C (median [IQR]) 36.5 (36.2–36.8) 36.5 (36–36.9) 36.4 (36.2–36.8) 36.2 36.8 0.57
Peripheral RDT (n/N of positive [%]) 6/21 (28.6) 0 6/13 (46.2) 0 0 0.052
Peripheral microscopy (n/N of positive [%]) 9/22 (40.9) 1/7 (14.3) 8/13 (61.5) 0 0 0.070
Spleen blood microscopy (n/N of positive [%]) 13/22 (59.1) 3/7 (42.9) 10/13 (76.9) 0 0 0.17
Spleen histology (n/N of positive [%]) 15/17 (88.2) 6/6 (100) 9/10 (90) - 0 0.44
Peripheral blood PCR (n/N of positive [%]) 17/21 (81.0) 7/7 (100) 9/12 (75) 1 (100) 0 0.16
Spleen PCR (n/N of positive [%]) 21/22 (95.5) 7/7 (100) 13/13 (100) 1(100) 0 -
Treated with antimalarials in the last month (n/N, [%]) 4/22 (18.2) 1/7 (14.3) 4/13 (30.8) 0 0 0.61
Treated with antimalarials after surgery (n/N, [%]) 17/22 (77.3) 5/7 (71.4) 11/13 (84.6) 1 (100) 0 0.49
First infection in the next 12 months with P. vivax (n/N, [%]) 11/18 (61.1) 5/5 (100) 5/11 (45.5) 1 (100) 0 0.043
First infection in the next 12 months with P. falciparum (n/N, [%]) 3/18 (16.7) 0 3/11 (27.3) 0 0 0.51

IQR, interquartile range; RDT, rapid diagnostic test.

*Continuous variables were compared using the Mann–Whitney test, and categorical variables using the chi-squared test or Fisher exact test. P value <0.05 considered statistically significant.